Prognostic factors in patients with small renal masses: a comparison between <2 vs. 2.1–4 cm renal cell carcinomas-Reference-Cited by-同舟云学术

Prognostic factors in patients with small renal masses: a comparison between <2 vs. 2.1–4 cm renal cell carcinomas

Published:2020-11-09 Issue:2 Volume:32 Page:119-126
ISSN:0957-5243
Container-title:Cancer Causes & Control
language:en
Short-container-title:Cancer Causes Control

Author:

Rosiello Giuseppe^ORCID,Pecoraro Angela,Luzzago Stefano,Deuker Marina,Stolzenbach Lara Franziska,Tian Zhe,Larcher Alessandro,Capitanio Umberto,Montorsi Francesco,Shariat Shahrokh F.,Kapoor Anil,Saad Fred,Briganti Alberto,Karakiewicz Pierre I.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10552-020-01364-3.pdf

Reference20 articles.

1. Nguyen MM, Gill IS, Ellison LM (2006) The evolving presentation of renal carcinoma in the United States: trends from the surveillance, epidemiology, and end results program. J Urol 176:2397–2400. https://doi.org/10.1016/j.juro.2006.07.144

2. Patel HD, Gupta M, Joice GA, Srivastava A, Alam R, Allaf ME et al (2019) Clinical stage migration and survival for renal cell carcinoma in the United States. Eur Urol Oncol 2:343–348. https://doi.org/10.1016/j.euo.2018.08.023

3. Luzzago S, Palumbo C, Rosiello G, Knipper S, Pecoraro A, Mistretta FA et al (2020) Effect of stage and grade migration on cancer specific mortality in renal cell carcinoma patients, according to clear cell vs. non-clear cell histology: a contemporary population-based analysis. Urol Oncol Semin Original Invest 38:506–514. https://doi.org/10.1016/j.urolonc.2020.02.004

4. Palumbo C, Pecoraro A, Rosiello G, Luzzago S, Deuker M, Stolzenbach F et al (2020) Renal cell carcinoma incidence rates and trends in young adults aged 20-39 years. Cancer Epidemiol 67:101762. https://doi.org/10.1016/j.canep.2020.101762

5. Capitanio U, Bensalah K, Bex A, Boorjian SA, Bray F, Coleman J et al (2019) Epidemiology of renal cell carcinoma. Eur Urol 75:74–84. https://doi.org/10.1016/j.eururo.2018.08.036

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Re: Sarah P. Psutka, Roman Gulati, Michael A.S. Jewett, et al. A Clinical Decision Aid to Support Personalized Treatment Selection for Patients with Clinical T1 Renal Masses: Results from a Multi-institutional Competing-risks Analysis. Eur Urol 2022;81:576–85;European Urology;2022-11

2. Authors’ Reply: To Letter to the Editor by Guo and Liu;Journal of the National Comprehensive Cancer Network;2021-05